Keywords: |
cancer chemotherapy; cancer survival; treatment outcome; disease-free survival; cancer surgery; clinical trial; review; postoperative period; cisplatin; fluorouracil; multimodality cancer therapy; skin toxicity; cancer adjuvant therapy; cancer radiotherapy; chemotherapy, adjuvant; radiotherapy, adjuvant; antimetabolites, antineoplastic; blood toxicity; gastrointestinal symptom; mucosa inflammation; colonic neoplasms; colorectal carcinoma; colorectal neoplasms; folinic acid; colon cancer; drug infusion; rectal neoplasms; rectum cancer; clinical trials; anus sphincter; levamisole; preoperative radiotherapy; semustine; humans; human; priority journal
|